Real-world treatment attrition rates in advanced esophagogastric cancer

BACKGROUND: Over the last decade, multiple agents have demonstrated efficacy for advanced esophagogastric cancer (EGC). Despite the availability of later lines of therapy, there remains limited real-world data about the treatment attrition rates between lines of therapy. AIM: To characterize the use...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsang, Erica S, Lim, Howard J, Renouf, Daniel J, Davies, Janine M, Loree, Jonathan M, Gill, Sharlene
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2020
Materias:
Retrospective Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7584053/
https://www.ncbi.nlm.nih.gov/pubmed/33132652
http://dx.doi.org/10.3748/wjg.v26.i39.6027

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7584053/
https://www.ncbi.nlm.nih.gov/pubmed/33132652
http://dx.doi.org/10.3748/wjg.v26.i39.6027

Ejemplares similares